Clinical Trial Update: Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immune response of the HPV vaccine in HIV-infected women has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Sexually Transmitted Diseases

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Sexually Transmitted Diseases | Phase 2 | Status: COMPLETED | Results posted: 2013-10-17